Beneficial effects of n-3 fatty acids on cardiometabolic and inflammatory markers in type 2 diabetes mellitus: a clinical trial

Maryam, Mazaherioun; Mahmoud, Djalali; Fariba, Koohdani; Mohammad, Javanbakht; Mahnaz, Zarei; Maani, Beigy; Samaneh, Ansari; Neda, Rezvan; Ahmad, Saedisomeolia

Maryam, Mazaherioun; Mahmoud, Djalali; Fariba, Koohdani; Mohammad, Javanbakht; Mahnaz, Zarei; Maani, Beigy; Samaneh, Ansari; Neda, Rezvan; Ahmad, Saedisomeolia.

Medical Principles and Practice. 2017; 26 (6): 535-541

in English | IMEMR | ID: emr-197080

Responsible library: EMRO

ABSTRACT

ABSTRACT

Objective:

Jo determine the effect of supplementation with n-3 polyunsaturated fatty acids (PUFAs) on circulatory resis-tin and monocyte chemoattractant protein 1 [MCP-1] levels in type 2 diabetes mellitus [T2DM] patients

Search on Google

XML

Index: IMEMR (Eastern Mediterranean) Type of study: Controlled clinical trial Language: English Journal: Med. Princ. Pract. Year: 2017

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

Index: IMEMR (Eastern Mediterranean) Type of study: Controlled clinical trial Language: English Journal: Med. Princ. Pract. Year: 2017